2025
Modeling survival outcomes of KEYNOTE-564 with standard of care control arm treatment: A simulation study.
Ghali F, Rahman S, James S. Modeling survival outcomes of KEYNOTE-564 with standard of care control arm treatment: A simulation study. Journal Of Clinical Oncology 2025, 43: 517-517. DOI: 10.1200/jco.2025.43.5_suppl.517.Peer-Reviewed Original ResearchStandard of careKEYNOTE-564KEYNOTE-426Renal cell carcinomaCheckpoint inhibitorsUnadjusted hazard ratioOverall survivalControl armHazard ratioPatient-level survival dataFirst-line settingImproved overall survivalProportion of patientsKaplan-Meier plotsMortality riskSurvival parametersControl group patientsOne-year mortality riskCell carcinomaFirst-lineSurvival outcomesControl patientsGroup patientsSurvival curvesArm treatment
2024
Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion
Reinhardt S, Gibson D, Hsu J, Kapadia S, Yeh R, Price M, Piccini J, Nair D, Christen T, Allocco D, Freeman J. Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion. Journal Of The American College Of Cardiology 2024, 84: 889-900. PMID: 39197978, DOI: 10.1016/j.jacc.2024.05.067.Peer-Reviewed Original ResearchConceptsLeft atrial appendage occlusionRate of adverse eventsAdverse eventsLAA closure deviceAppendage occlusionAntithrombotic strategiesP2Y<sub>12</sub> inhibitorsDays of follow-upMultivariable Cox proportional hazards regressionClosure deviceRisk of adverse eventsCox proportional hazards regressionWatchman FLX deviceDual antiplatelet therapyDevice-related thrombusProportional hazards regressionStroke/transient ischemic attackAntithrombotic regimensFLX deviceAntiplatelet therapyDOACsGroup patientsFollow-upMultivariate analysisHazards regressionOptimizing Total Hip and Knee Arthroplasty Among an Underserved Population: Lessons Learned From a Quality-Improvement Initiative
El-Othmani M, McCormick K, Xu W, Hickernell T, Sarpong N, Tyler W, Herndon C. Optimizing Total Hip and Knee Arthroplasty Among an Underserved Population: Lessons Learned From a Quality-Improvement Initiative. Arthroplasty Today 2024, 28: 101443. PMID: 38983938, PMCID: PMC11231561, DOI: 10.1016/j.artd.2024.101443.Peer-Reviewed Original ResearchTotal joint arthroplastyAmerican Society of Anesthesiologists scoreUnderserved populationsPreoperative optimization protocolElective total joint arthroplastyQuality improvement initiativesQuality-improvement initiativesContemporary control cohortPostoperative complicationsReoperation ratePostoperative outcomesAnesthesiologists scorePatient demographicsClinical group patientsRetrospective analysisGroup patientsMedical comorbiditiesControl cohortHealth equityOffice patientsPatient populationMedicaid clinicComplicationsQuality-improvementImprovement initiativesThe Impact of Preprocedural Platelet Function Testing on Periprocedural Complication Rates Associated With Pipeline Flow Diversion: An International Multicenter Study
Vranic J, Dmytriw A, Berglar I, Alotaibi N, Cancelliere N, Stapleton C, Rabinov J, Harker P, Gupta R, Bernstock J, Koch M, Raymond S, Mascitelli J, Patterson T, Seinfeld J, White A, Case D, Roark C, Gandhi C, Al-Mufti F, Cooper J, Matouk C, Sujijantarat N, Devia D, Ocampo-Navia M, Villamizar-Torres D, Puentes J, Salem M, Baig A, Namaani K, Kühn A, Pukenas B, Jankowitz B, Burkhardt J, Siddiqui A, Jabbour P, Singh J, Puri A, Regenhardt R, Pereira V, Patel A. The Impact of Preprocedural Platelet Function Testing on Periprocedural Complication Rates Associated With Pipeline Flow Diversion: An International Multicenter Study. Neurosurgery 2024, 95: 179-185. PMID: 38634693, DOI: 10.1227/neu.0000000000002956.Peer-Reviewed Original ResearchPlatelet function testsPipeline Embolization DeviceDual antiplatelet therapyGroup patientsIntracranial complicationsDAPT regimenThromboembolic complicationsPED treatment of intracranial aneurysmsResults of platelet function testingPipeline Embolization Device embolizationPipeline Embolization Device treatmentFunction testsIntracranial aneurysmsPipeline flow diversionPermanent neurological disabilityInternational multicenter studyFlow diversionTreatment of intracranial aneurysmsUnruptured intracranial aneurysmsWilcoxon rank-sumClopidogrel nonrespondersComplication rateMulticenter studyAntiplatelet therapyFisher's exact
2022
Unsupervised Machine Learning To Define Acute Hfpef Phenotypes: Findings From Ascend-hf
Murray E, Greene S, Rao V, Sun J, Alhanti B, Blumer V, Butler J, Ahmad T, Hernandez A, Mentz R. Unsupervised Machine Learning To Define Acute Hfpef Phenotypes: Findings From Ascend-hf. Journal Of Cardiac Failure 2022, 28: s10-s11. DOI: 10.1016/j.cardfail.2022.03.029.Peer-Reviewed Original ResearchSystolic blood pressureHFpEF phenotypeGroup patientsBaseline characteristicsBlood pressureHeart rateHigher systolic blood pressureLower systolic blood pressureDistinct baseline characteristicsDistinct patient phenotypesClinical trial cohortNatriuretic peptide concentrationsASCEND-HF trialTime of admissionFuture clinical trialsDistinct clinical outcomesLower heart rateHigher heart rateDistinct phenotypesHigh rateMedical comorbiditiesTrial cohortClinical profileEjection fractionHeart failureImpact of chronic kidney disease on in-hospital mortality and clinical outcomes of catheter ablation of ventricular tachycardia: Insights from the national readmission database
Khalil M, Maraey A, Aglan A, Akintoye E, Salem M, Elzanaty A, Younes A, Saeyeldin A, Barbhaiya C, Shokr M. Impact of chronic kidney disease on in-hospital mortality and clinical outcomes of catheter ablation of ventricular tachycardia: Insights from the national readmission database. Journal Of Interventional Cardiac Electrophysiology 2022, 66: 323-331. PMID: 35314904, DOI: 10.1007/s10840-022-01187-z.Peer-Reviewed Original ResearchConceptsChronic kidney diseaseNational Readmission DatabaseClinical outcomesVentricular tachycardiaCatheter ablationKidney diseaseHospital mortalityVT ablationOdds ratioCorresponding diagnosis codesUnderwent catheter ablationAcute kidney injuryTotal hospital chargesWorse clinical outcomesMean lengthMultivariable regression analysisCKD groupConclusionIn patientsGroup patientsKidney injurySecondary outcomesHospital chargesDiagnosis codesClinical dataEffective treatmentIndex Admission Cholecystectomy and Recurrence of Pediatric Gallstone Pancreatitis: Multicenter Cohort Analysis.
Muñoz Abraham AS, Osei H, Bajinting A, Cowles RA, Greenspon J, Hosfield BD, Keller MS, Landman MP, Owens H, Shaughnessy MP, St Peter SD, Sujka J, Vogel AM, Villalona GA. Index Admission Cholecystectomy and Recurrence of Pediatric Gallstone Pancreatitis: Multicenter Cohort Analysis. Journal Of The American College Of Surgeons 2022, 234: 352-358. PMID: 35213498, DOI: 10.1097/xcs.0000000000000062.Peer-Reviewed Original ResearchConceptsGallstone pancreatitisEarly cholecystectomyIndex admissionRecurrent pancreatitisRecurrence rateMean body mass indexIndex admission cholecystectomyMean age 13.5Multicenter cohort analysisTiming of cholecystectomyBody mass indexBiliary complicationsInterval cholecystectomyIndex dischargeCholecystectomy ratesGroup patientsMost patientsLaboratory characteristicsMild pancreatitisPediatric patientsRetrospective reviewMass indexCholecystectomyCohort analysisPancreatitis
2020
Regional cerebral oximetry is consistent across self-reported racial groups and predicts 30-day mortality in cardiac surgery: a retrospective analysis
Stannard B, Levin M, Lin H, Weiner M. Regional cerebral oximetry is consistent across self-reported racial groups and predicts 30-day mortality in cardiac surgery: a retrospective analysis. Journal Of Clinical Monitoring And Computing 2020, 35: 413-421. PMID: 32086678, DOI: 10.1007/s10877-020-00487-x.Peer-Reviewed Original ResearchConceptsCardiac surgerySelf-reported racePerioperative variablesAsian patientsAssociated with increased 30-day mortalityOn-pump cardiac surgeryPredicting 30-day mortalityOximetry measurementsPredicting adverse outcomesRegional cerebral oximetryRegional oxygen saturationCerebral oximetry devicesCerebral oximetry measurementsAfrican American patientsSelf-reported racial groupsDarker skin pigmentationMultiple logistic regressionCaucasian patientsAdult patientsRisk stratificationPacific Islander patientsGroup patientsRetrospective analysisRSO2 readingsCerebral oximetry
2019
Differences in trends in the use of robot‐assisted and open radical cystectomy and changes over time in peri‐operative outcomes among selected centres in North America and Europe: an international multicentre collaboration
Zamboni S, Soria F, Mathieu R, Xylinas E, Abufaraj M, D`Andrea D, Tan W, Kelly J, Simone G, Gallucci M, Meraney A, Krishna S, Konety B, Antonelli A, Simeone C, Baumeister P, Mattei A, Briganti A, Gallina A, Montorsi F, Rink M, Aziz A, Karakiewicz P, Rouprêt M, Koupparis A, Scherr D, Ploussard G, Sooriakumaran P, Shariat S, Moschini M, Urologists U. Differences in trends in the use of robot‐assisted and open radical cystectomy and changes over time in peri‐operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. BJU International 2019, 124: 656-664. PMID: 31055865, DOI: 10.1111/bju.14791.Peer-Reviewed Original ResearchRobot-assisted radical cystectomyOpen radical cystectomyPeri-operative outcomesRadical cystectomyNorth American centresContemporary patientsPatients treated with open radical cystectomyEuropean centresPatients treated with robot-assisted radical cystectomyLower American Society of Anesthesiologists scoresAmerican Society of Anesthesiologists scoreLower blood lossRe-operation rateAmerican centresInternational multicentre collaborationContemporary seriesT stageBlood lossEarly complicationsRe-operationAnesthesiologists scoreBladder cancerGroup patientsRetrospective evaluationCystectomyIliac venous stenting for outflow obstruction does not significantly change the quality of life of patients with severe chronic venous insufficiency
Shiferson A, Aboian E, Shih M, Pu Q, Jacob T, Rhee RY. Iliac venous stenting for outflow obstruction does not significantly change the quality of life of patients with severe chronic venous insufficiency. JRSM Cardiovascular Disease 2019, 8: 2048004019890968. PMID: 31839939, PMCID: PMC6893555, DOI: 10.1177/2048004019890968.Peer-Reviewed Original ResearchIliac venous stentingChronic venous insufficiencyQuality of lifeAdvanced chronic venous insufficiencyChronic venous insufficiency patientsOutflow obstructionVenous stentingGroup patientsVenous insufficiencyIntravascular ultrasonographyStented groupChronic Venous Insufficiency QualitySevere chronic venous insufficiencyCIVIQ-20 questionnaireCIVIQ-20 scoresNon-stented groupConservative medical managementCase-control studyIliac venous systemQuestionnaire one yearCEAP 5CIVIQ-20Outflow stenosisPersistent painIliac stenting
2016
Telemonitoring Adherence to Medications in Heart Failure Patients (TEAM-HF): A Pilot Randomized Clinical Trial
Gallagher BD, Moise N, Haerizadeh M, Ye S, Medina V, Kronish IM. Telemonitoring Adherence to Medications in Heart Failure Patients (TEAM-HF): A Pilot Randomized Clinical Trial. Journal Of Cardiac Failure 2016, 23: 345-349. PMID: 27818309, PMCID: PMC5380538, DOI: 10.1016/j.cardfail.2016.11.001.Peer-Reviewed Original ResearchConceptsHeart failurePercent of patientsHeart failure patientsEligible patientsGroup patientsFailure patientsMost patientsMedian ageMedication nonadherenceMedication adherenceTelephonic supportAdherence devicesAdherence monitoringPassive adherenceClinical trialsPatientsAdherenceNonadherenceFuture studiesDaysPercentReadmissionHospitalizationMedicationsTrials
2015
Moderate Versus Deep Hypothermic Circulatory Arrest for Elective Aortic Transverse Hemiarch Reconstruction
Vallabhajosyula P, Jassar AS, Menon RS, Komlo C, Gutsche J, Desai ND, Hargrove WC, Bavaria JE, Szeto WY. Moderate Versus Deep Hypothermic Circulatory Arrest for Elective Aortic Transverse Hemiarch Reconstruction. The Annals Of Thoracic Surgery 2015, 99: 1511-1517. PMID: 25825200, DOI: 10.1016/j.athoracsur.2014.12.067.Peer-Reviewed Original ResearchConceptsModerate hypothermic circulatory arrestDeep hypothermic circulatory arrestHypothermic circulatory arrestDirect innominate artery cannulationAntegrade cerebral perfusionInnominate artery cannulationCerebral perfusionCirculatory arrestHemiarch reconstructionTransfusion requirementsArtery cannulationMHCA groupCerebral perfusion strategyCerebral protection strategiesConcomitant root replacementRetrograde cerebral perfusionAortic valve replacementFresh frozen plasmaAortic aneurysm diseaseHemodialysis rateAortic reconstructionNeurologic complicationsGroup patientsPostoperative outcomesRoot replacementSeparation anxiety disorder in adult patients with obsessive-compulsive disorder: Prevalence and clinical correlates
Franz A, Rateke L, Hartmann T, McLaughlin N, Torres A, do Rosário M, Filho E, Ferrão Y. Separation anxiety disorder in adult patients with obsessive-compulsive disorder: Prevalence and clinical correlates. European Psychiatry 2015, 30: 145-151. PMID: 24908152, DOI: 10.1016/j.eurpsy.2014.04.007.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderSeparation anxiety disorderPsychiatric comorbidityAnxiety disordersMore psychiatric comorbiditiesCross-sectional studyMultiple logistic regressionSpecific psychiatric comorbiditiesPrimary obsessive-compulsive disorderBrazilian Research ConsortiumSensory phenomenaGroup patientsAdult patientsHigh morbidityClinical correlatesSymptom assessmentPoor responsePrognostic evaluationLifetime diagnosisPatientsSuch symptomsSocio-demographic variablesLogistic regressionOCD patientsDisorders
2014
Valve-sparing root reimplantation and leaflet repair in a bicuspid aortic valve: Comparison with the 3-cusp David procedure
Bavaria JE, Desai N, Szeto WY, Komlo C, Rhode T, Wallen T, Vallabhajosyula P. Valve-sparing root reimplantation and leaflet repair in a bicuspid aortic valve: Comparison with the 3-cusp David procedure. Journal Of Thoracic And Cardiovascular Surgery 2014, 149: s22-s28. PMID: 25500099, DOI: 10.1016/j.jtcvs.2014.10.103.Peer-Reviewed Original ResearchMeSH KeywordsAdultAortic AneurysmAortic ValveAortic Valve InsufficiencyBicuspid Aortic Valve DiseaseBlood Vessel Prosthesis ImplantationCardiac Surgical ProceduresDisease-Free SurvivalFemaleHeart Valve DiseasesHemodynamicsHumansKaplan-Meier EstimateMaleMiddle AgedReoperationReplantationRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeConceptsValve-sparing root reimplantationAortic valve patientsBAV patientsAI gradeMidterm outcomesAortic insufficiencyTransvalvular gradientValve patientsRoot reimplantationLeaflet repairEntire cohortBicuspid aortic valve patientsTricuspid aortic valve patientsAortic valve reoperationPrimary valve repairBicuspid aortic valveExcellent midterm outcomesActuarial freedomPostoperative freedomPostoperative mortalityValve reoperationBAV groupGroup patientsPacemaker requirementRetrospective reviewTreatment‐Related Mortality With Everolimus in Cancer Patients
Wesolowski R, Abdel‐Rasoul M, Lustberg M, Paskell M, Shapiro C, Macrae E. Treatment‐Related Mortality With Everolimus in Cancer Patients. The Oncologist 2014, 19: 661-668. PMID: 24794158, PMCID: PMC4041666, DOI: 10.1634/theoncologist.2013-0355.Peer-Reviewed Original ResearchConceptsFatal adverse eventsTreatment-related mortalityCancer patientsAdverse eventsOverall incidenceSan Antonio Breast Cancer SymposiumRole of everolimusControl group patientsMultiple solid tumorsEverolimus administrationGroup patientsCancer SymposiumSubgroup analysisControl armOdds ratioEverolimusFatal eventsClinical OncologyPatientsSolid tumorsPubMed databaseTumor typesIncidenceAmerican SocietySignificant differences
2009
Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners
Lindell KO, Olshansky E, Song MK, Zullo TG, Gibson KF, Kaminski N, Hoffman LA. Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners. Heart & Lung 2009, 39: 304-313. PMID: 20561836, PMCID: PMC3467095, DOI: 10.1016/j.hrtlng.2009.08.005.Peer-Reviewed Original ResearchMeSH KeywordsAdaptation, PsychologicalAgedAnalysis of VarianceAnxietyCaregiversDepressionDisease ManagementDisease ProgressionFemaleHealth Status IndicatorsHumansIdiopathic Pulmonary FibrosisMalePilot ProjectsPsychometricsQuality of LifeRespiratory Function TestsStress, PsychologicalSurveys and QuestionnairesUnited StatesConceptsDisease management interventionsAdvanced lung diseaseHealth-related qualityIdiopathic pulmonary fibrosisSymptom burdenLung diseaseCare partnersPulmonary fibrosisExperimental group participantsTime of diagnosisInterstitial lung diseaseExperimental group patientsGroup participantsPittsburgh Medical CenterDisease management programsPulmonary fibrosis resultsGroup patientsRespiratory failureUsual careMedian survivalIntervention groupPatient participantsMedical CenterFibrosis resultsPatientsImpact of Myocardial Bridge on Clinical Outcome After Coronary Stent Placement
Tsujita K, Maehara A, Mintz GS, Doi H, Kubo T, Castellanos C, Liu J, Yang J, Oviedo C, Franklin-Bond T, Sugirtharaj DD, Dangas GD, Lansky AJ, Stone GW, Moses JW, Leon MB, Mehran R. Impact of Myocardial Bridge on Clinical Outcome After Coronary Stent Placement. The American Journal Of Cardiology 2009, 103: 1344-1348. PMID: 19427426, DOI: 10.1016/j.amjcard.2009.01.340.Peer-Reviewed Original ResearchConceptsTarget lesion revascularizationCoronary stent placementStent placementMyocardial bridgeArtery lesionsObstructive lesionsClinical outcomesStent groupTarget lesion revascularization rateStent group patientsTarget vessel revascularizationComposite end pointCoronary artery lesionsMinimum stent areaGroup patientsRevascularization ratesConsecutive patientsLeft anteriorObstructive diseaseSystolic compressionCoronary arterySignificant plaqueStent areaStent restenosisIntravascular ultrasound
2008
Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction: A Study by the National Cancer Institute Organ Dysfunction Working Group
Gibbons J, Egorin M, Ramanathan R, Fu P, Mulkerin D, Shibata S, Takimoto C, Mani S, LoRusso P, Grem J, Pavlick A, Lenz H, Flick S, Reynolds S, Lagattuta T, Parise R, Wang Y, Murgo A, Ivy S, Remick S. Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Renal Dysfunction: A Study by the National Cancer Institute Organ Dysfunction Working Group. Journal Of Clinical Oncology 2008, 26: 570-576. PMID: 18235116, DOI: 10.1200/jco.2007.13.3819.Peer-Reviewed Original ResearchConceptsMaximum-tolerated doseSerious adverse eventsDose-limiting toxicityImatinib dosesGroup patientsRenal dysfunctionImatinib exposureNormal groupNational Cancer Institute Organ Dysfunction Working GroupAlpha-1-acid glycoprotein concentrationSerum alpha-1-acid glycoprotein concentrationsMild group patientsRenal dysfunction groupModerate renal dysfunctionAdvanced solid tumorsPharmacokinetics of imatinibAcid glycoprotein concentrationPlasma AGP concentrationImatinib clearanceImatinib dosePlasma imatinibStable diseaseDysfunction groupRenal impairmentAdult patients
2003
Group Prenatal Care and Preterm Birth Weight
Ickovics JR, Kershaw TS, Westdahl C, Rising SS, Klima C, Reynolds H, Magriples U. Group Prenatal Care and Preterm Birth Weight. Obstetrics And Gynecology 2003, 102: 1051-1057. DOI: 10.1097/00006250-200311000-00030.Peer-Reviewed Original ResearchConceptsGroup prenatal careIndividual prenatal careLow birth weightPrenatal careBirth weightGroup patientsGestational agePreterm birth weightAdverse perinatal outcomesInfants of womenSame gestational ageHigh birth weightInfant birth dateProvider-patient interactionsLow socioeconomic statusPerinatal outcomesCohort studyPrenatal visitEarly pretermHealthy pregnancyWeeks' gestationPregnant womenPrenatal servicesPublic clinicsCare results
2000
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
Bensen W, Zhao S, Burke T, Zabinski R, Makuch R, Maurath C, Agrawal N, Geis G. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo. The Journal Of Rheumatology 2000, 27: 1876-83. PMID: 10955327.Peer-Reviewed Original ResearchMeSH KeywordsAbdominal PainAnti-Inflammatory Agents, Non-SteroidalArthritis, RheumatoidCelecoxibCyclooxygenase 2Cyclooxygenase 2 InhibitorsCyclooxygenase InhibitorsDigestive SystemDouble-Blind MethodDyspepsiaFemaleHumansIsoenzymesMaleMembrane ProteinsMiddle AgedNaproxenNauseaOsteoarthritisProspective StudiesProstaglandin-Endoperoxide SynthasesPyrazolesRisk FactorsSulfonamidesTime FactorsTreatment OutcomeConceptsUpper gastrointestinal tolerabilityUpper GI symptomsSevere abdominal painComposite endpointAbdominal painGastrointestinal tolerabilityGI symptomsIndependent predictorsRheumatoid arthritisRelative riskCOX-2-specific inhibitorsUpper GI tolerabilityTreatment group patientsDose-response relationshipGI tolerabilityPlacebo patientsGroup patientsCumulative incidenceParallel groupClinical trialsPlaceboPatientsCelecoxibTolerabilityEndpoint
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply